Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection

Background: Previous studies suggest S100A9 is a promising biomarker for prognosis in cancer, including hepatocellular carcinoma (HCC). We examined the utility of serum S100A9 in predicting prognosis in HCC after curative resection. Methods: We conducted a retrospective study of 379 HCC patients who...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Cancer
Hoofdauteurs: Meng, Jun, Gu, Feng, Fang, Hua, Qu, Bin
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Ivyspring International Publisher 2019
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6360318/
https://ncbi.nlm.nih.gov/pubmed/30719134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.28409
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items